The Apoptotic Mechanism of Action of the Sphingosine Kinase 1 Selective Inhibitor SKI-178 in Human Acute Myeloid Leukemia Cell Lines-Reference-Cited by-同舟云学术

The Apoptotic Mechanism of Action of the Sphingosine Kinase 1 Selective Inhibitor SKI-178 in Human Acute Myeloid Leukemia Cell Lines

Published:2015-01-06 Issue:3 Volume:352 Page:494-508
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Dick Taryn E.,Hengst Jeremy A.,Fox Todd E.,Colledge Ashley L.,Kale Vijay P.,Sung Shen-Shu,Sharma Arun,Amin Shantu,Loughran Thomas P.,Kester Mark,Wang Hong-Gang,Yun Jong K.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference100 articles.

1. Novel agents targeting bioactive sphingolipids for the treatment of cancer;Adan-Gokbulut;Curr Med Chem,2013

2. Bcl-xL controls a switch between cell death modes during mitotic arrest

3. Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine;Baran;Exp Oncol,2006

4. p14ARF Interacts with the SUMO-Conjugating Enzyme Ubc9 and Promotes the Sumoylation of Its Binding Partners

5. Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax;Pharmaceutics;2024-01-31

2. Sphingosine-1-phosphate mediates FSH-induced cell viability but not steroidogenesis in bovine granulosa cells;Theriogenology;2024-01

3. FANNING THE FLAMES OF ER STRESS:Can sphingolipid metabolism be targeted to enhance ER stress associated immunogenic cell death in cancer?;Molecular Pharmacology;2023-12-21

4. Sphingosine 1-phosphate signaling during infection and immunity;Progress in Lipid Research;2023-11

5. Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth;Cell Death & Disease;2023-08-21